Functionalized azobenzene platinum(II) complexes as putative anticancer compounds.

J Biol Inorg Chem

Departament de Química, Facultat de Ciències, Universitat Autònoma de Barcelona, 08193-Cerdanyola del Vallès, Barcelona, Spain.

Published: June 2021

The synthesis and characterization of four platinum(II) complexes using azobenzenes conveniently functionalized as ligands has been carried out. The characteristic photochemical behavior of the complexes due to the presence of azobenzene-type ligands and the role of the ligands in the activation of the complexes has been studied. Their promising cytotoxicity observed in HeLa cells prompted us to study the mechanism of action of these complexes as cytostatic agents. The interaction of the compounds with DNA, studied by circular dichroism, revealed a differential activity of the Pt(II) complexes upon irradiation. The intercalation abilities of the complexes as well as their reactivity with common proteins present in the blood stream allows to confirm some of the compounds obtained as good anticancer candidates.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00775-021-01865-9DOI Listing

Publication Analysis

Top Keywords

platinumii complexes
8
complexes
7
functionalized azobenzene
4
azobenzene platinumii
4
complexes putative
4
putative anticancer
4
anticancer compounds
4
compounds synthesis
4
synthesis characterization
4
characterization platinumii
4

Similar Publications

The discovery of cisplatin (cisPt) as an effective anticancer agent was a milestone in the health industry. Despite its success, undesired side effects and acquired resistance still limit the therapeutic usefulness of cisPt. Intrastrand adduct formation at consecutive purines and structural modifications of DNA caused by platinum(II) complexes are important factors for antitumor efficacy.

View Article and Find Full Text PDF

Transition metal complexes are well-known for their efficient light emission and are promising for applications ranging from bioimaging to light-emitting diodes. In solution, interactions between the metal centers of two complexes become possible and drastically change the photophysical properties. For real-world devices, solid-state materials consisting of these molecules are preferable.

View Article and Find Full Text PDF

Recent advances in ruthenium (III) complex-loaded nanomaterial for enhanced cancer therapy efficacy.

Drug Dev Ind Pharm

January 2025

Guangxi Key Laboratory of Drug Discovery and Optimization, School of Pharmacy, Guilin Medical University, Guilin, China.

Objective: Amid the escalating global cancer incidence, the development of effective and safe anticancer drugs is a critical priority in medical research. Addressing the clinical shortcomings of ruthenium-based anticancer drugs are currently a prominent focus of research.

Significance And Methods: Since the pioneering work with platinum derivatives, significant progress has been made in the fundamental studies of metal complexes for the treatment of a wide range of cancers, and there has been a growing interest in their properties and biomedical applications.

View Article and Find Full Text PDF

Carbazolylpyridine ()-based tetradentate platinum(II) complexes containing fused 6/5/6 metallocycles.

Dalton Trans

January 2025

College of Chemical Engineering, State Key Laboratory Breeding Base of Green-Chemical Synthesis Technology, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, P. R. China.

A series of carbazolylpyridine ()-based 6/5/6 Pt(II) complexes featuring tetradentate ligands with nitrogen or oxygen atoms as bridging groups was designed and synthesized, and the bridging nitrogen atoms were derived from acridinyl (Ac), azaaceridine (AAc) and carbazole (Cz). Systematic experimental and theoretical studies reveal that the ligand structures have a significant effect on the electrochemical, photophysical and excited state properties of these complexes. Their oxidation processes mainly occur on the carbazole-Pt moieties, whereas the reduction processes typically occur on the electron-deficient pyridine (Py) moieties.

View Article and Find Full Text PDF

Correction for 'A novel platinum(II) complex with a berberine derivative as a potential antitumor agent targeting G-quadruplex DNA' by Shu-Lin Zhang , , 2025, https://doi.org/10.1039/d4ob01705f.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!